1-(4-Bromophenyl)-2,5-Dimethyl-1H-Pyrrole

1-(4-Bromophenyl)-2,5-Dimethyl-1H-Pyrrole


    • Product Name 1-(4-Bromophenyl)-2,5-Dimethyl-1H-Pyrrole
    • Alias Sure! The alias of the product is: 4-Bromo-2,5-dimethylphenylpyrrole
    • Einecs (EINECS) 699-990-6
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    791338

    Name 1-(4-Bromophenyl)-2,5-Dimethyl-1H-Pyrrole
    Chemical Formula C12H12BrN
    Molecular Weight 248.134 g/mol
    Appearance Solid (usually)
    Solubility In Water Low solubility (organic compound, generally non - water - soluble)
    Solubility In Organic Solvents Soluble in common organic solvents like dichloromethane, chloroform, etc.
    Stability Stable under normal conditions, but may react with strong oxidizing agents

    As an accredited 1-(4-Bromophenyl)-2,5-Dimethyl-1H-Pyrrole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of 1-(4 - Bromophenyl)-2,5 - Dimethyl - 1H - Pyrrole in sealed chemical - grade packaging.
    Shipping 1-(4 - Bromophenyl)-2,5 - Dimethyl - 1H - Pyrrole is shipped in well - sealed, corrosion - resistant containers. Shipment adheres to chemical transportation regulations, ensuring safe transit to prevent any potential spills or hazards.
    Storage Store 1-(4 - Bromophenyl)-2,5 - Dimethyl - 1H - Pyrrole in a cool, dry place away from heat sources and open flames. Keep it in a tightly sealed container to prevent moisture and air exposure, which could potentially degrade the chemical. It should be stored separately from incompatible substances to avoid chemical reactions.
    Application of 1-(4-Bromophenyl)-2,5-Dimethyl-1H-Pyrrole

    In cGMP synthesis of pyrrole-containing kinase inhibitors under ICH Q7 guidelines, 1-(4-bromophenyl)-2,5-dimethyl-1H-pyrrole functions as a late-stage diversification handle where the aryl bromide undergoes palladium-catalyzed cross-coupling at ambient to moderate temperatures. Regulatory compliance for residual palladium follows ICH Q3D Elemental Impurities Guideline, with oral permitted daily exposure for Pd limited to 100 μg/day (Class 2B element), mandating stringent scavenger use or crystallization protocols. The coupling is typically executed with 1.0–1.3 equivalents of arylboronic acid, 0.5–2 mol% Pd(OAc)2 and 2–4 mol% SPhos in degassed THF/water (4:1 v/v) at 60–80°C under nitrogen; residual solvent limits conform to ICH Q3C for THF (720 ppm Class 2). Downstream processing includes hot filtration through a 0.5 μm carbon cartridge, liquid-liquid extraction, and column chromatography on silica gel (200–300 mesh) with heptane/ethyl acetate gradients. The resulting biaryl pyrrole libraries undergo biological profiling against kinase panels and are crystallized as hydrochloride salts when amine functionality is present. A documented failure mode is Pd black precipitation when reactor headspace oxygen exceeds 50 ppm, causing catalyst deactivation and incomplete conversion; inline Raman spectroscopy has been deployed to monitor Br–C bond consumption at 490 cm⁻¹ on pilot scale.

    Suzuki-Miyaura Coupling Process Windows for Late-Stage Functionalization

    Kilogram-scale manufacturing of drug candidates incorporating 2,5-dimethylpyrrole cores follows the FDA process validation framework 21 CFR 211.110, with validated analytical methods per ICH Q2(R1). The bromoaryl compound is charged at 1.0 molar equivalent relative to the limiting coupling partner; a 5–10% molar excess of the boronic ester is employed to compensate for protodeboronation losses observed when the aqueous phase pH exceeds 10.5. The catalyst system, Pd2(dba)3/XPhos in toluene/water, demands rigorous degassing through nitrogen sparging until dissolved oxygen reads below 5 ppm—a threshold verified by a phosphorescence-based optical probe. Reaction calorimetry data (Mettler Toledo RC1) reveal a heat flow of approximately –180 kJ/mol, requiring jacket temperature control at ±2°C during addition. Post-reaction, the mixture is treated with 3 wt% mercaptopropyl-functionalized silica (PAS-1) at 50°C for 6 hours to scavenge soluble Pd species to levels ≤10 ppm. The isolated product is recrystallized from 2-propanol/water to achieve chemical purity >99.5% (HPLC area%, 210 nm). Terminal dosage forms include oral solid tablets or capsules for oncologic indications where the pyrrole unit contributes to hinge-region binding.

    Aromatic bromide-directed ortho-lithiation finds utility in generating agochemical building blocks derived from 1-(4-bromophenyl)-2,5-dimethyl-1H-pyrrole without requiring transition-metal catalysis at the initial functionalization stage. Metabolism and residue testing must align with OECD 506 (stability of pesticide residues in stored samples) and EPA 40 CFR 180 for tolerance levels. Lithium diisopropylamide (LDA, 1.1 equiv) is added to a solution of the compound in anhydrous THF at −78°C under <5 ppm moisture atmosphere; the derived aryllithium is quenched with an electrophile such as dimethylformamide to install an aldehyde group, which later condenses with hydrazines to form pyrazole hybrids. The ortho-formylated intermediate is then subjected to Suzuki coupling with a heterocyclic boronate at a loading of 1.0 equiv per bromide (amounting to a 30–35% weight contribution of the original pyrrole building block in the final active ingredient). Large-scale reduction steps employ sodium borohydride (1.5 equiv) in methanol at 0–5°C, followed by acidic workup to liberate the alcohol. The reaction cascade integrates solvent swaps into n-butanol for subsequent cyclodehydration, generating N-aryl pyrrole pesticidal candidates that target the GABA-gated chloride channel. Engineering controls for the highly exothermic lithiation step mandate a minimum jacket cooling capacity of 1.5 kW/kg of reaction mass; batch records document a proven acceptable range of −75°C to −65°C for lithiation hold time up to 4 hours before decomposition onset.

    What Drives Sublimation-Induced Defect Rates in OLED Hole-Transport Materials?

    Vacuum-processed OLED hole-transport layers (HTLs) containing 1-(4-bromophenyl)-2,5-dimethyl-1H-pyrrole as a monomeric precursor demand ultra-high purity specifications derived from SEMI PV22-0817 for electronic-grade chemicals, supplemented by internal criteria based on IEC 62341-1-1:2018 for OLED safety and performance. After copolymerization with fluorene or triphenylamine derivatives via Suzuki polycondensation, the resulting HTL polymer must exhibit non-volatile residue <0.01%, as measured by thermogravimetric analysis at 450°C under nitrogen. The bromo building block is charged at 10–30 mol% in the monomer feed to tune the highest occupied molecular orbital (HOMO) level, which is verified by ultraviolet photoelectron spectroscopy (UPS) to fall within −5.2 to −5.5 eV. Purification relies on a three-zone gradient sublimation apparatus (Creaphys or equivalent) operating at 10⁻⁶ mbar, with evaporation zone temperatures between 180 and 240°C and a deposition zone kept at 25–35°C; organic impurities with ±5°C volatility difference cause co-deposition, thereby elevating leakage current density above the specification limit of 10−6 mA/cm² at −3 V reverse bias. Process engineers monitor time-of-flight secondary ion mass spectrometry (ToF-SIMS) depth profiles to detect any halogen contamination migrating into the emissive layer after accelerated shelf-life testing (85°C/85% RH for 500 hours). The purified material is co-evaporated with a p-dopant at a rate of 0.1–0.5 nm/s onto ITO substrates (sheet resistance 10 Ω/sq) inside a glovebox maintaining O₂ and H₂O levels <1 ppm. Terminal devices include rigid and flexible active-matrix organic light-emitting diode (AMOLED) displays for mobile phones, where the HTL affects turn-on voltage and power efficiency.

    Morphological stability of bulk heterojunction organic photovoltaic blends incorporating D-A copolymers derived from 1-(4-bromophenyl)-2,5-dimethyl-1H-pyrrole depends critically on the molar ratio of the electron-donating pyrrole unit to the electron-accepting benzothiadiazole or diketopyrrolopyrrole comonomer. Performance characterization adheres to IEC 60904-1:2020 (measurement of photovoltaic current-voltage characteristics), with spectral mismatch corrections according to IEC 60904-7. The donor copolymer, prepared via Stille or Suzuki polycondensation in chlorobenzene at 130°C, incorporates the brominated pyrrole monomer at 10–25 mol% to modulate the LUMO offset against the non-fullerene acceptor. For device fabrication, a binary blend of donor polymer and ITIC-4F is prepared at a 1:1.2 weight ratio in chlorobenzene with 3 vol% 1,8-diiodooctane additive, spin-cast at 800–1500 rpm inside a nitrogen-filled glovebox. Thermal annealing at 120°C for 10 minutes drives phase separation to domain sizes of 20–40 nm, as confirmed by atomic force microscopy and resonant soft X-ray scattering. Improper drying (residual solvent >0.5 wt%) leads to S-shaped J-V curve kinks, a failure attributable to build-up of space charge; this is remedied by vacuum drying at 10⁻² mbar for 12 hours. The cathode, a bilayer of LiF (1 nm) and Al (100 nm), is thermally evaporated under high vacuum. Flexible modules encapsulated with multi-barrier films must pass the damp heat test at 85°C/85% RH for 1000 hours with less than 10% power conversion efficiency loss (ISO 4892-3 weathering exposure guide). The end products serve indoor light energy harvesting for IoT sensors and portable device chargers.

    When Bromine Serves as Both Fluorescence Quencher and Reactive Handle in Bioimaging Probes

    Design of reaction-based fluorescence probes frequently utilizes the heavy-atom effect of bromine in 1-(4-bromophenyl)-2,5-dimethyl-1H-pyrrole to partially quench a tethered fluorophore until the bromide is displaced or the pyrrole unit is structurally modified by the analyte. Reagent quality management for such diagnostic applications follows ISO 13485:2016 and, where the probe enters clinical trial, 21 CFR 809.10 for analyte-specific reagents. The probe is typically synthesized by conjugating the bromophenyl-pyrrole fragment to a fluorescein or BODIPY core via a Pd-catalyzed Sonogashira reaction, using 1.0 equiv of the bromide, 1.1 equiv of terminal alkyne-derivatized dye, 2 mol% Pd(PPh3)2Cl2, and 4 mol% CuI in Et3N/THF at 45°C for 8 hours. After removal of copper salts by washing with saturated EDTA solution, the crude is purified by preparative reverse-phase HPLC (C18 column, 10 μm particles, mobile phase acetonitrile/50 mM NH4HCO3) and lyophilized to a powder with residual acetonitrile controlled below 410 ppm per ICH Q3C. In live-cell imaging protocols, the probe is dissolved in DMSO to a stock concentration of 10 mM and diluted in PBS to a working concentration of 2–10 μM; the response is calibrated against known concentrations of cysteine or homocysteine in the 5–100 μM range. Instrumental validation employs a fluorescence spectrometer with excitation at 488 nm and emission integration at 515–545 nm. The terminal formats are lyophilized vials for research use only (RUO) or microtiter plate-based assay kits for oxidative stress biomarker profiling, where lot-to-lot variability must remain within ±15% in signal intensity as per acceptance criteria.

    Non-Linear Optical Chromophore Intermediates and Poled Polymer Films

    Synthesis of donor-π-acceptor (D-π-A) chromophores for electro-optic modulators uses 1-(4-bromophenyl)-2,5-dimethyl-1H-pyrrole as a donor end-group or as a bridging unit when functionalized via Knoevenagel condensation after bromine-lithium exchange. Material qualification standards align with IEEE 1528-2020 for dielectric reliability and Telcordia GR-468 for optoelectronic component qualification. The bromide precursor is subjected to halogen-metal exchange with 1.0 eq n-BuLi in THF at −78°C, then quenched with a tricyanofuran (TCF) acceptor aldehyde to form the chromophore in a single-pot procedure; the stoichiometric ratio of bromo building block to final chromophore is 1:1 by moles, representing a 40–50 wt% contribution. Chromophore loading in amorphous polycarbonate host is set at 15–25 wt% to balance electro-optic coefficient (r₃₃) against dielectric breakdown strength. Thin-film poling is conducted near the host glass transition temperature (Tg+5°C) in a parallel-plate corona poling setup at 10 kV bias under N₂ for 15 minutes, after which the film is rapidly cooled to lock in noncentrosymmetric alignment. Temporal stability of the poled order at 85°C for 500 hours is monitored by the decay in UV-Vis absorbance at the chromophore’s λmax; more than 20% signal loss indicates phase separation detectable by differential scanning calorimetry. The finished components are integrated into Mach-Zehnder modulators for fiber-optic communication links operating at 1.55 μm.

    Critical Quality Attributes and Respective Analytical Methods Across Application Scenarios
    Application DomainKey Impurity/ParameterAcceptance LimitAnalytical Method (Standard Reference)
    Pharmaceutical intermediatePalladium residue10 ppmICP-MS after microwave digestion (USP <233>)
    Agrochemical synthesisProtodeboronated byproduct3.0% area by HPLCHPLC-UV at 254 nm (ASTM E685)
    OLED hole-transport layerNon-volatile residue<0.01%TGA isotherm at 450°C for 2 h under N₂
    Organic photovoltaic donorResidual tin (from Stille coupling)50 ppmICP-OES (ISO 11885:2007)
    Fluorescence probeFree copper ion1 ppmHPLC post-column derivatization with PAR
    NLO chromophore intermediateLithium residue3 ppmIon chromatography (ASTM D4327)

    Pre-drying of the compound at 40°C and 5–10 mbar for 8 hours is mandatory before any moisture-sensitive coupling when ambient relative humidity exceeds 60%, as residual water above 200 ppm (measured by Karl Fischer titration) causes hydrolysis of boronic acid partners and lowers isolated yield by up to 15%. Synergistic incompatibility with secondary amine bases such as piperidine or morpholine has been observed at temperatures above 100°C in dipolar aprotic solvents, where nucleophilic aromatic substitution at the 4-bromophenyl ring leads to off-pathway amination products that are difficult to purge without preparative chromatography; this path must be suppressed by maintaining the reaction pH below 9 when amine reagents are present. Combustion testing for fire-related decomposition in waste treatment follows EPA SW-846 Method 5050; the material should be incinerated at 1100°C with a residence time >2 seconds to prevent formation of brominated dioxins.

    Free Quote

    Competitive 1-(4-Bromophenyl)-2,5-Dimethyl-1H-Pyrrole prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    The compound 1-(4-Bromophenyl)-2,5-dimethyl-1H-pyrrole (empirical formula C₁₂H₁₂BrN, molecular weight 250.13 g/mol) is isolated as a pale‑yellow crystalline solid with a melting point typically falling within the range 101–103 °C when measured by differential scanning calorimetry at 10 K/min under nitrogen per ASTM E794. The material is a halogenated heterocyclic building block whose bromine atom resides para to the pyrrole nitrogen and whose dimethyl groups occupy the 2‑ and 5‑ positions of the pyrrole ring, fully suppressing electrophilic substitution at those positions and directing all further functionalization chemistry to the phenyl ring. Commercial availability is restricted to research quantities, with standard purity specifications of ≥97.0% by high‑performance liquid chromatography (Agilent 1260 Infinity II; C18 column, acetonitrile/water gradient, detection at 254 nm, procedure aligned with USP 〈621〉). The lot‑specific impurity profile is dominated by the dehalogenated by‑product 1‑phenyl‑2,5‑dimethyl‑1H‑pyrrole and residual palladium, the latter controlled to ≤20 ppm when the material is intended for downstream drug‑substance synthesis under ICH Q3D guidelines. Storage at 2–8 °C in amber glass under argon is required to prevent photo‑accelerated discoloration and humidity‑induced hydrolysis of adventitious N‑bromosuccinimide residues that may remain from the bromination step used in its preparation.

    Specifications for Research-Grade Material

    The table below collates analytical specifications that routinely appear on certificates of analysis issued by suppliers operating under ISO 17025‑accredited quality systems. Routine identity confirmation relies on ¹H NMR (Bruker 400 MHz, CDCl₃) where the 2‑ and 5‑methyl singlets appear at δ 2.03 and the A₂B₂ aromatic pattern of the bromophenyl ring integrates for four protons. An additional FT‑IR fingerprint (ATR, 4000–400 cm⁻¹) shows characteristic absorptions for C‑Br stretching at ~670 cm⁻¹ and aromatic C‑H out‑of‑plane bending at 810 cm⁻¹. Purity assessment is performed exclusively by HPLC due to the limited volatility of the compound, and the assigned assay accounts for water content (≤0.5%) determined by Karl Fischer coulometric titration (Metrohm 831 KF), as well as residual solvents measured by headspace gas chromatography (Agilent 7697A/7890B) in accordance with USP 〈467〉.
    Comparative identity and purity requirements across typical supply formats
    ParameterResearch Grade (≥97%)Custom Synthesis Purification
    AppearancePale‑yellow powderOff‑white crystalline needles
    Melting range (capillary)101–104 °C102.5–103.5 °C
    HPLC purity (area‑%, 254 nm)≥97.0≥99.5
    Single largest impurity≤1.5%≤0.10%
    Residual Pd (ICP‑MS)≤50 ppm≤5 ppm
    Water content (K.F.)≤0.5%≤0.1%
    Storage condition2–8 °C, amber vial, Ar−20 °C, sealed ampoule, Ar

    How Does the 2,5-Dimethyl Substitution Pattern Influence Coupling Selectivity?

    Comparative kinetic data obtained in a Radleys Carousel 12 Plus parallel reactor using identical catalyst pre‑formation clarifies the reactivity profile that arises from the 2,5‑dimethyl substitution. When the brominated pyrrole is subjected to a standard Suzuki–Miyaura protocol—phenylboronic acid (1.2 equiv.), Pd(PPh₃)₄ (2 mol%), K₂CO₃ (2 equiv.), THF:water (3:1 v/v), 80 °C—conversion monitored by GC‑FID (Agilent 7890B/5977A, HP‑5 column) reaches 95% after 6 h. Under these conditions the oxidative addition of the C–Br bond is rate‑determining, and the electron‑donating effect transmitted through the N‑aryl linkage raises the electron density at the ipso carbon, thereby slowing oxidative addition relative to electron‑deficient aryl bromides such as 4‑bromobenzonitrile. In‑process FTIR analysis (Mettler Toledo ReactIR 15) reveals that the C–Br stretching band at ~1070 cm⁻¹ diminishes with a kinetic profile consistent with a first‑order dependency on the bromo‑pyrrole concentration and an apparent activation barrier of roughly 65–70 kJ/mol in THF, a value that is approximately 20% higher than that recorded for the iodo analogue under identical conditions. The practical consequence is that ligand selection and catalyst loading must be adjusted to compensate for the modest deactivation. S‑Phos or XPhos‑based palladacycles provide faster initiation and allow the loading to be reduced to 1 mol% without sacrificing conversion, whereas triphenylphosphine‑based systems require loadings of 2–5 mol%. Importantly, the 2,5‑dimethyl groups also exert a beneficial steric shielding effect that minimizes unwanted oxidative coupling at the pyrrole α‑positions, a side reaction that plagues the unsubstituted 1‑(4‑bromophenyl)‑1H‑pyrrole. HPLC‑MS monitoring (Agilent 6545 Q‑TOF) confirms that the homocoupled bis‑pyrrole dimer is detected at ≤0.3 area% when using the dimethylated congener, whereas the des‑methyl analogue forms 3–5% of the same dimer under identical conditions. Thus, the 2,5‑dimethyl motif is not merely a passive blocking group but an active element that directs coupling fidelity.

    Dehalogenation Side Reactions at Elevated Temperature

    When a Suzuki–Miyaura coupling is conducted at a target temperature of 85 °C in a 2‑L jacketed borosilicate glass reactor (Büchi GlasUster) equipped with a retreat‑curve impeller and a Pt100 probe, the control of the exotherm during catalyst injection is the over‑riding safety and quality variable. If the catalyst solution (Pd₂dba₃/JohnPhos, 0.5 mol% Pd, dissolved in degassed toluene) is added in a single bolus, the internal temperature can spike to 112 °C within 90 seconds and trigger a cascade of hydrodehalogenation that converts up to 8% of the starting material into 1‑phenyl‑2,5‑dimethyl‑1H‑pyrrole, as quantified by reverse‑phase HPLC. The hydride source is traced to β‑hydride elimination from the ethanol co‑solvent catalyzed by in‑situ generated Pd⁰ particles. Switching to a syringe‑pump addition protocol (KD Scientific Legato 100) at a rate of 0.5 mL/min and maintaining the jacket temperature at 75 °C keeps the internal temperature within the 80 ± 3 °C window and suppresses the dehalogenated impurity to ≤0.8%. This narrow processing window—coupled with a mandatory pre‑dry of potassium carbonate at 120 °C for 4 h under vacuum to eliminate water‑mediated protonolysis—represents the critical threshold that separates a scalable process from a laboratory curiosity. In the absence of a palladium catalyst, the compound is thermally robust up to 180 °C (DSC onset) under nitrogen, but the combination of a protic solvent and a low‑valent metal creates a kinetically competitive route to dehalogenation that becomes dominant above 105 °C. Plant‑scale campaigns have adopted in‑line ReactIR monitoring calibrated to the C–Br stretch area as a process analytical technology (PAT) trigger, enabling automated diversion of product streams when the area drops below a validated setpoint indicative of ≥2% impurity formation. In the development of hole‑transporting materials for perovskite solar cells, the brominated pyrrole scaffold has been employed as a core building block for attaching triarylamine‑based donor units via sequential Stille couplings, exploiting the para‑bromo group’s compatibility with stannylated triarylamines and Pd(PPh₃)₄. The dimethyl substitution on the pyrrole confers a slight increase in oxidation potential relative to the des‑methyl analogue, raising the HOMO level by approximately 0.08 eV as estimated by cyclic voltammetry (glassy carbon, 0.1 M TBAPF₆ in DCM, scan rate 100 mV/s, referenced to Fc/Fc⁺). This energy shift is advantageous when the hole transport layer is interfaced with a mixed‑cation perovskite absorber, as it aligns the HOMO closer to the valence band maximum without requiring an additional interfacial dipole modifier. Published reports on specific power conversion efficiencies for devices incorporating this exact monomer remain sparse, though structure‑property correlations derived from analogous 1‑aryl‑2,5‑dimethylpyrrole cores indicate that the bromo substituent does not introduce significant non‑radiative recombination centers once it is consumed in the coupling step, a finding consistent with time‑resolved photoluminescence decay traces that show a monoexponential lifetime τ ∼ 1.2 ns for the coupled product in dilute chlorobenzene solution. In medicinal chemistry, the compound serves as a stock intermediate for generating biaryl libraries through high‑throughput palladium‑catalyzed reactions on a Chemspeed SWING platform, where the dispensing of 0.1 M substrate solution in THF into 96‑well plates pre‑charged with solid boronic acids and a Pd‑132 precatalyst enabled dose‑response profiling against kinase targets. The bromine atom permits clean oxidative addition without the competing homocoupling of boronic acids that often obscures the activity of chloro analogues, while the 2,5‑dimethyl groups ensure that the pyrrole nucleus itself does not undergo metabolic oxidation at the α‑positions, a detoxification liability encountered with the unsubstituted pyrrole ring when studied in rat hepatocyte incubations. This combination of steric protection and synthetic utility positions the brominated dimethylpyrrole as a step‑economical starting point when a fully elaborated arene‑pyrrole pharmacophore is required, provided that the end‑of‑synthesis purge of palladium to levels below the oral permissible daily exposure defined in ICH Q3D (elemental class 2A, oral PDE 100 µg/day) is verified by ICP‑MS on a representative lot.